Europe's transplant diagnostics market set for 5% annual growth over next five years
This article was originally published in Clinica
The European market for immunosuppressive drug monitoring kits in 1998 was valued at $25.1 million, according to a new report from Frost & Sullivan.
You may also be interested in...
Roche has partnered with Regeneron and Atea, but the company continues to leverage its long legacy in infectious diseases to identify good treatment options for the novel coronavirus.
Resilience has raised $800m to develop new technologies to manufacture complex drugs including vaccines, cell therapies and gene therapies.
Results of three-year study conducted at 17 Canadian sites suggest that e-cigarettes use combined with counseling significantly increased abstinence from smoking cigarettes compared to receiving counseling alone.